PHR
PHREESIA (PHR)
NYSE
$9.02+$0.10 (+1.12%)
Price as of Jun 23, 2026 6:18 PM EDT
  • $551.4M
    Market Cap
  • -66.99%
    1-Year Change
  • Health Information Services
    Industry

Key Performance

More
  • Earnings Score: 73
  • Momentum Score: 5
  • True Yield: N/A
  • Financial Health Score: 89
TradeSmith Loading

Latest Research & News

PHREESIA DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Phreesia, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - PHR

Rosen Law Firm reminds Phreesia, Inc. investors who purchased stock between May 8, 2025 and March 30, 2026 of the July 13, 2026 lead plaintiff deadline in a securities class action. The lawsuit alleges that Phreesia made false statements and concealed material facts regarding slowing demand and reduced visibility in key revenue streams, particularly weakened pharmaceutical marketing commitments in its Network Solutions segment.

06/22/2026, 10:39 PM • GlobeNewswire

PHR UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Phreesia (PHR) Investors of Securities Class Action Lawsuit Deadline on July 13, 2026

A federal securities class action has been filed against Phreesia, Inc. (NYSE: PHR) alleging that the company and its executives made false and misleading statements about growth opportunities while concealing slowing demand and weakening pharmaceutical marketing commitments. After Phreesia announced significantly reduced revenue guidance on March 30, 2026, the stock price fell approximately 27% from $11.41 to $8.38 per share. Investors who purchased PHR stock between May 8, 2025 and March 30, 2026 have until July 13, 2026 to seek lead plaintiff appointment.

06/20/2026, 8:56 AM • GlobeNewswire

PHREESIA DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Phreesia, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - PHR

Rosen Law Firm is notifying Phreesia, Inc. investors who purchased stock between May 8, 2025 and March 30, 2026 of an important July 13, 2026 deadline to serve as lead plaintiff in a securities class action. The lawsuit alleges that Phreesia made false statements and concealed material facts regarding slowing demand and weakened pharmaceutical marketing commitments in its Network Solutions segment, resulting in investor damages.

06/19/2026, 3:25 PM • GlobeNewswire

Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against Phreesia, Inc. (PHR), AeroVironment, Inc. (AVAV), and Lucid Group, Inc. (LCID) Announced by Holzer & Holzer, LLC

Holzer & Holzer, LLC announces lead plaintiff deadlines for shareholder class action lawsuits against three companies. Phreesia faces allegations of false statements regarding long-term growth outlook (deadline July 13, 2026). AeroVironment is accused of misrepresenting its competitive landscape (deadline July 27, 2026). Lucid Group faces claims about false statements regarding manufacturing and delivery capabilities (deadline July 28, 2026). Investors who purchased shares during the alleged fraud periods and suffered losses are encouraged to contact the firm.

06/18/2026, 3:56 PM • GlobeNewswire

Bragar Eagel & Squire, P.C. Reminds Phreesia, Inc. (NYSE:PHR) Investors that a Class Action Lawsuit Has Been Filed Against Phreesia and Encourages Investors to Contact the Firm

A class action lawsuit has been filed against Phreesia, Inc. (NYSE:PHR) in the U.S. District Court for the District of Delaware, alleging that the company and its executives made false or misleading statements regarding revenue visibility. The company significantly reduced its FY 2027 revenue guidance from $545-$559 million to $510-$520 million on March 30, 2026, citing weaker pharmaceutical-marketing commitments and reduced visibility in its Network Solutions segment—risks that were not disclosed during the December 8, 2025 earnings call. The stock fell 21-28% following the revised outlook.

06/15/2026, 5:59 PM • GlobeNewswire

DEADLINE ALERT for PHR, SRAD, CVLT, VERI: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions

Law Offices of Howard G. Smith announced securities fraud class action lawsuits against four publicly-traded companies. Phreesia Inc. faces allegations of misrepresenting growth projections, Sportradar Group AG is accused of working with black-market gambling operators while claiming compliance, Commvault Systems Inc. allegedly failed to properly account for sales type impacts on ARR growth, and Veritone Inc. is charged with revenue misclassification and deficient internal controls. Investors have until mid-July 2026 to file lead plaintiff motions.

06/15/2026, 1:31 PM • GlobeNewswire

Bronstein, Gewirtz & Grossman LLC Urges Phreesia, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

A class action lawsuit has been filed against Phreesia, Inc. alleging securities fraud. The complaint claims the company made false statements about its business prospects while experiencing slowing demand, diminished revenue visibility, and weakened pharmaceutical marketing commitments in its Network Solutions segment during the period from May 8, 2025 to March 30, 2026.

06/14/2026, 12:00 PM • GlobeNewswire

PHREESIA DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Phreesia, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PHR

Rosen Law Firm is notifying investors in Phreesia, Inc., Babcock & Wilcox Enterprises, Inc., and TruBridge, Inc. of ongoing securities class action lawsuits. Phreesia investors have until July 13, 2026 to serve as lead plaintiff. The lawsuit alleges Phreesia made false statements about slowing demand and reduced visibility in key revenue streams, particularly in its Network Solutions segment.

06/13/2026, 6:09 PM • GlobeNewswire

ROSEN, A LONGSTANDING FIRM, Encourages Phreesia, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PHR

Rosen Law Firm is seeking lead plaintiffs for a securities class action lawsuit against Phreesia, Inc. The lawsuit alleges that defendants made false and misleading statements regarding slowing demand and reduced visibility in key revenue streams, particularly weakened pharmaceutical marketing commitments in the Network Solutions segment. The lead plaintiff deadline is July 13, 2026.

06/10/2026, 2:54 PM • GlobeNewswire

Bronstein, Gewirtz & Grossman LLC Urges Phreesia, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

A class action lawsuit has been filed against Phreesia, Inc. alleging securities fraud. The complaint claims the company made false statements about its business prospects while concealing slowing demand, diminished revenue visibility, and weakened pharmaceutical marketing commitments in its Network Solutions segment during the period from May 8, 2025 to March 30, 2026.

06/10/2026, 12:00 PM • GlobeNewswire

DEADLINE ALERT for PHR, SRAD, CVLT, VERI: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions

Law Offices of Howard G. Smith has announced securities fraud class action lawsuits against four publicly-traded companies: Phreesia Inc., Sportradar Group AG, Commvault Systems Inc., and Veritone Inc. Investors have until mid-July 2026 to file lead plaintiff motions. The complaints allege various forms of misrepresentation including false growth projections, undisclosed compliance violations, misleading revenue guidance, and accounting irregularities.

06/09/2026, 12:54 PM • GlobeNewswire

Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against Graphic Packaging Holding Company (GPK), Immutep Limited (IMMP), and Phreesia, Inc. (PHR) Announced by Holzer & Holzer, LLC

Holzer & Holzer, LLC announced lead plaintiff deadlines for multiple shareholder class action lawsuits against companies including Graphic Packaging Holding Company, Immutep Limited, and Phreesia, Inc. The lawsuits allege materially false and misleading statements regarding inventory management, clinical trial prospects, and growth outlook. Investors who purchased shares during specified periods and suffered losses are encouraged to seek lead plaintiff status by the announced deadlines in July 2026.

06/08/2026, 8:00 AM • GlobeNewswire

ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Phreesia, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PHR

Rosen Law Firm is notifying Phreesia, Inc. (NYSE: PHR) investors who purchased stock between May 8, 2025 and March 30, 2026 about a securities class action lawsuit. The firm alleges that Phreesia made false or misleading statements regarding slowing demand and reduced visibility in key revenue streams, particularly weakened pharmaceutical marketing commitments in its Network Solutions segment. Investors have until July 13, 2026 to serve as lead plaintiff.

06/07/2026, 6:13 PM • GlobeNewswire

Bronstein, Gewirtz & Grossman LLC Urges Phreesia, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

A class action lawsuit has been filed against Phreesia, Inc. alleging that the company made materially false and misleading statements regarding its business performance. The complaint claims Phreesia failed to disclose slowing demand, diminished revenue visibility, and weakened pharmaceutical marketing commitments in its Network Solutions segment during the class period from May 8, 2025 to March 30, 2026.

06/07/2026, 12:00 PM • GlobeNewswire

Phreesia Inc. (PHR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

The Law Offices of Frank R. Cruz announced a securities fraud class action lawsuit against Phreesia Inc., alleging the company made false statements about its growth outlook and revenue projections between May 2025 and March 2026. The lawsuit claims Phreesia misrepresented the reliability of its pharmaceutical marketing commitments as a growth driver for its Network Solutions segment, putting its 2027 revenue targets at risk. Investors who suffered losses have until July 13, 2026 to participate as lead plaintiffs.

06/03/2026, 3:15 PM • Benzinga

Peers

Statistics

More
Day Range
$8.91
$9.52
$8.92
1-Year Range
$8.06
$32.55
$8.92
Latest Close$8.92
Change
-$0.46 (-5.16%)
Volume1,255,110
Market Cap$551.4M
Shares Outstanding61.8M
P/E (TTM)60.47
Diluted EPS (TTM)$0.15
Enterprise Value$567.3M

Information as of 06/22/2026

Company Profile

$551.4M
Market Cap
$9.2M
Net Income
Sector: Healthcare
Industry: Health Information Services
1521 Concord Pike, Wilmington, DE, United States, 19803
888 654 7473

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. It offers solutions including appointment optimization and referral management using AI-enabled workflows; and AI-based smart answering solution patient communications supported by voice and messaging solutions; integrated payment solutions embedded in intake and post-visit workflows, and financing solutions that enable healthcare organizations to accelerate cash collections while offering flexible payment options to patients; and digital intake and clinical data capture, patient engagement and activation tools, and measurement and analytics solutions. It also offers PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, which are on-site kiosks. The company serves a range of healthcare organizations including ambulatory practices, health systems, and hospitals, as well as life sciences companies, government entities, patient advocacy, public interest and not-for-profit and other organizations. Phreesia, Inc. was incorporated in 2005 and is based in Wilmington, Delaware.

Key Executives

  • David Linetsky
  • Chaim Indig
  • Evan Roberts
  • Balaji Gandhi
  • Allison C. Hoffman

Current Ownership Distribution

  • Institutions956.9M (71.83%)
  • Mutual Funds358.6M (26.92%)
  • Insiders16.7M (1.25%)
  • Other0 (0.00%)